Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Psoriasis × deucravacitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Conditions

Psoriasis 1 Prostatic Neoplasms 1

Interventions

tofacitinib 6 Etanercept 5 Methotrexate 3 Adalimumab 3 secukinumab 2 Nivolumab 2 sotrastaurin 1 deucravacitinib 1 calcipotriene 1 baricitinib 1 apremilast 1 Vitamin D 1 Specimen Handling 1 Folic Acid 1 Fish Oils 1 Fatty Acids, Omega-3 1 Exercise 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Biopsy 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06281106 2025-04-02

TYPP

Centre Hospitalier Universitaire Vaudois

Phase 2/3 Terminated

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡